EUVIMEDEUVIMED entdecken
Fallbericht

Dorsal root ganglion stimulator—A targeted therapy for post‐herpetic neuralgia: The Middle East Experience

Amit Verma iD, Eric Francois, Tanmoy Maiti, Leanne Cassidy, Reda Tolba

Pain Practice · 2024

DOI: 10.1111/papr.13325 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pain Practice, 2024. Verfasst von Amit Verma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Anaesthesiology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: Neuralgia, Postherpetic, Neuralgia, Herpes Zoster. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post herpetic neuralgia (PHN) is a chronic neuropathic pain syndrome which presents after an episode of herpes zoster caused by the reactivation of varicella zoster virus. Conservative treatment starts with pharmacological measures using Anti‐epileptics and Antidepressants. Some patients also respond well to epidural steroid injections too, but the effect is usually short lasting. Dorsal Root Ganglion Stimulator (DRG‐S) has recently been suggested as a new treatment modality for PHN due to its selective targeting of the pathophysiologic focus. Case Series We are reporting three cases, who were suffering from neuropathic pain after an episode of herpes zoster. Pain and pain related suffering scores were high, even with multiple antiepileptics and opioid medications. They underwent DRG‐S implant and appreciated more than 50% reduction of their pain score, meaningful reduction in the dose of medications along with significant improvement of their general well being measured using Generalized Anxiety Disorder Questionnaire (GAD‐7), pain disability index (PDI), and 9 Question Patient Health Questionnaire (PHQ‐9). To our knowledge this is the first report on DRG stimulator from the Middle East Region.

Conclusion

DRG‐S has potential to be a preferable treatment option in patients with refractory PHN and acts as a specific targeted therapy in the treatment of these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuralgia, PostherpeticNeuralgiaHerpes ZosterHumansGanglia, SpinalAnticonvulsants

Stichwörter der Autor:innen

dorsal root ganglion stimulationneuropathic painpost-herpetic neuralgia

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Anaesthesiology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
  • Neurosurgical Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.

ORCID-Profile: Amit Verma

Zitieren

APA

Verma, A., Francois, E., Maiti, T., Cassidy, L., & Tolba, R. (2024). Dorsal root ganglion stimulator—A targeted therapy for post‐herpetic neuralgia: The Middle East Experience. Pain Practice. https://doi.org/10.1111/papr.13325

Vancouver

Verma A, Francois E, Maiti T, Cassidy L, Tolba R. Dorsal root ganglion stimulator—A targeted therapy for post‐herpetic neuralgia: The Middle East Experience. Pain Practice. 2024. doi:10.1111/papr.13325

BibTeX
@article{Verma2024,
  author = {Verma, Amit and Francois, Eric and Maiti, Tanmoy and Cassidy, Leanne and Tolba, Reda},
  title = {Dorsal root ganglion stimulator—A targeted therapy for post‐herpetic neuralgia: The Middle East Experience},
  journal = {Pain Practice},
  year = {2024},
  doi = {10.1111/papr.13325}
}
Kostenlos starten →